|
|
Recent Articles
-
Something New!
Oct 30, 2022
-
Hi everyone: To stay true to our mission, you'll find something new regarding our methodology. In the coming weeks, you'll see this table in our work going forward.
-
In the News: META, AAPL, AMZN, RSG, DLR, VRTX, XOM, CVX
Oct 28, 2022
-
Image Source: Valuentum.
Readers should expect a substantial reduction in our fair value estimate of Meta Platforms on the basis of materially reduced forecasts of free cash flow. Apple’s calendar third-quarter results were good, considering that many were worried about iPhone 14 demand heading into the report. Amazon’s results support a cautious tone with respect to consumer spending, while we remain bullish on three of our best-performing ideas so far in 2022 – Vertex Pharma, Exxon Mobil, and Chevron. We didn’t see anything in the Republic Services and Digital Realty reports that would warrant any material changes to our theses at this time.
-
Dividend Increases/Decreases for the Week of October 28
Oct 28, 2022
-
Let's take a look at firms raising/lowering their dividends this week.
-
VBI Ratings Not as Impressive As We Would Have Liked in 2022
Oct 27, 2022
-
Image: How the VBI rating system has ranked equities so far this year.
At Valuentum, we use the Valuentum Buying Index (VBI) to source ideas into diversified simulated newsletter portfolios, and the VBI may be most applicable to the simulated Best Ideas Newsletter portfolio, where we generally like to include ideas when they register a high VBI rating and remove them when they register a low VBI rating. We always use the VBI in a portfolio setting and never by itself. Let's talk more about the VBI rating system in this work.
|
